Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Vitamin Biomarkers Market Size Changed, over the years?

In the past few years, the size of the vitamin biomarkers market has increased swiftly. It is projected to expand from $3.59 billion in 2024 to $4.06 billion in 2025, experiencing a compound annual growth rate (CAGR) of 13.1%. The escalation during the historic period can be linked to the heightened awareness of vitamin deficiencies, increased incidence of chronic diseases, surging demand for personalized nutrition, ramped up research on nutritional biomarkers, and an increasing elderly population.

How Much Will the Vitamin Biomarkers Market Be Worth in 2029?

In the coming years, the vitamin biomarkers market is forecasted to experience robust growth, with its market value expected to hit $6.56 billion in 2029, expanding at a compound annual growth rate (CAGR) of 12.7%. The surge in growth in the projection period is linked to the upsurge in the uptake of digital health solutions, increasing emphasis on early disease identification, growing demand for home testing kits, a rise in healthcare spending, and heightened consumer focus on health and wellness. The forecast period is characterized by emerging trends such as the incorporation of wearable health tech, the creation of multi-biomarker panels, advances in high-throughput screening techniques, the introduction of innovative biomarker-based tests, and improvements in digital and remote health tracking.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21003&type=smp

Which is the Largest Company in the Vitamin Biomarkers Market?

Major companies operating in the vitamin biomarkers market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Roche Diagnostics International Ltd., Agilent Technologies Inc, PerkinElmer Inc, bioMérieux SA, Beckman Coulter Inc, Shimadzu Corporation, QuidelOrtho Corporation, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc, Tecan Group Ltd, Randox Laboratories Ltd, Ortho Clinical Diagnostics Inc, Molecular Devices LLC, Cambridge Isotope Laboratories Inc, Luminex Corporation, DiaSorin SpA, Analytik Jena AG, SeraCare Life Sciences Inc, Biopanda Reagents Ltd, SiPhox Inc

What Are the Main Market Drivers in the Vitamin Biomarkers Industry?

The rise in nutritional deficiencies is predicted to boost the vitamin biomarkers market’s growth in the future. Nutritional deficiencies occur when there are insufficient essential nutrients in the diet, resulting in negative health impacts. Factors such as poor diet, limited access to a variety of foods, and socio-economic conditions contribute to the growing incidence of nutritional deficiencies. Vitamin biomarkers diagnose these deficiencies by determining the certain vitamins in the blood to evaluate the nutritional status and suggest interventions. For example, a report from the Food and Agriculture Organization, an Italy-based non-profit organization, indicated in July 2023 that the prevalence of undernourishment impacted nearly 9.2% of the world’s population in 2022, an increase from 7.9% in 2021. In Africa, the prevalence increased by 0.3 percentage points from 19.4% in 2021 to 19.7% in 2022. Thus, the rising incidence of nutritional deficiencies will fuel the vitamin biomarkers market’s growth. In the vitamin biomarkers market, the growing emphasis on personalized medicine is likely to stimulate growth. Personalized medicine is defined as a medical model that customizes healthcare approaches and treatments according to each patient’s unique characteristics, genetics, and needs. Progress in genomics, biotechnology, and data analysis enables personalized medicine, allowing treatments to be tailored based on a person’s genetic makeup and other personal health information. Vitamin biomarkers aid personalized medicine by providing a glimpse into an individual’s nutritional status and metabolic activity, facilitating the design of tailored treatment plans to maximize health benefits. According to the Personlaized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for rare diseases in 2023, compared to 6 in 2022. The new approvals for 2023 also included seven cancer medications and three for other diseases and conditions. As a result, the growing emphasis on personalized medicine is driving the vitamin biomarkers market’s expansion.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=21003&type=smp

How Is the Vitamin Biomarkers Market Segments Structured?

The vitamin biomarkers market covered in this report is segmented –

1) By Biomarker Type: Serum Retinol (Vitamin A); Ascorbic Acid (Vitamin C); Serum 25(OH)D (Vitamin D); Serum Alpha-tocopherol (Vitamin E); Serum Prothrombin (Vitamin K); Serum Thiamine Diphosphate (Vitamin B1); Serum Glycolate (Vitamin B2); Serum Niacin (Vitamin B3); Serum Plasma PLP (Vitamin B6); Other Biomarker Types

2) By Product: Analyzers; Test Kits; Reagents And Consumables

3) By Testing Method: Enzyme Linked Immunosorbent Assay (ELISA); Liquid Chromatography With Tandem Mass Spectrometry (LC MS MS); High Performance Liquid Chromatography (HPLC); Chemiluminescent Immunoassay (CLIA)

4) By End User: Hospitals; Diagnostic Laboratories; Ambulatory Diagnostic Centers; Homecare Settings

Subsegments:

1) By Serum Retinol (Vitamin A): Retinol Measurement Kits; Retinol Assay Reagents

2) By Ascorbic Acid (Vitamin C): Vitamin C Detection Kits; Ascorbic Acid Assay Reagents

3) By Serum 25(OH)D (Vitamin D): Vitamin D Testing Kits; 25-Hydroxyvitamin D Assay Reagents

4) By Serum Alpha-tocopherol (Vitamin E): Alpha-tocopherol Measurement Kits; Vitamin E Assay Reagents

5) By Serum Prothrombin (Vitamin K): Prothrombin Time Testing Kits; Vitamin K Assay Reagents

6) By Serum Thiamine Diphosphate (Vitamin B1): Thiamine Measurement Kits; Vitamin B1 Assay Reagents

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vitamin-biomarkers-global-market-report

Which Global Regions Offer the Highest Growth in the Vitamin Biomarkers Market?

North America was the largest region in the vitamin biomarkers market in 2024. The regions covered in the vitamin biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21003

This Report Delivers Insight On:

1. How big is the vitamin biomarkers market, and how is it changing globally?

2. Who are the major companies in the vitamin biomarkers market, and how are they performing?

3. What are the key opportunities and risks in the vitamin biomarkers market right now?

4. Which products or customer segments are growing the most in the vitamin biomarkers market?

5. What factors are helping or slowing down the growth of the vitamin biomarkers market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model